Khalid Farooqui
Impact in
-
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 2
-
- Vitamin D Research Studies 5
- Co-authors
- Ambrish Mithal (10 shared papers)Mohammad Shafi Kuchay (7 shared papers)Sunil Kumar Mishra (4 shared papers)Parjeet Kaur (3 shared papers)Narendra S. Choudhary (2 shared papers)Manish Kumar Singh (2 shared papers)Sonal Krishan (2 shared papers)Ganesh Jevalikar (8 shared papers)
In The Last Decade
Khalid Farooqui
28 papers receiving 995 citations
Khalid Farooqui's Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 427
- Epidemiology 466
- Hepatology 67
- Pathology and Forensic Medicine 98
- Surgery 182
Countries citing papers authored by Khalid Farooqui
This map shows the geographic impact of Khalid Farooqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Farooqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Farooqui more than expected).
Fields of papers citing papers by Khalid Farooqui
This network shows the impact of papers produced by Khalid Farooqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Farooqui. The network helps show where Khalid Farooqui may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid Farooqui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) Hit paper breakdown → | 2018 | 488 |
| 2 | 2020 | 178 | |
| 3 | 2021 | 63 | |
| 4 | 2020 | 52 | |
| 5 | 2004 | 51 | |
| 6 | 2017 | 45 | |
| 7 | 2021 | 29 | |
| 8 | 2021 | 23 | |
| 9 | 2023 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2018 | 9 | |
| 12 | 2013 | 9 | |
| 13 | 2018 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2011 | 5 | |
| 16 | 2016 | 5 | |
| 17 | 2018 | 4 | |
| 18 | 2011 | 4 | |
| 19 | 2017 | 4 | |
| 20 | 2021 | 3 |
About Khalid Farooqui
Khalid Farooqui is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Genetics, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes and associated disorders (5 papers), Vitamin D Research Studies (5 papers), COVID-19 Clinical Research Studies (4 papers), Bone health and osteoporosis research (3 papers), Vitamin C and Antioxidants Research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Adrenal Hormones and Disorders (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (427 citations), Epidemiology (466 citations), Hepatology (67 citations), Pathology and Forensic Medicine (98 citations) and Surgery (182 citations). Khalid Farooqui has collaborated with scholars based in India, Qatar and Pakistan. Frequent co-authors include Ambrish Mithal, Mohammad Shafi Kuchay, Sunil Kumar Mishra, Parjeet Kaur, Narendra S. Choudhary, Manish Kumar Singh, Sonal Krishan, Ganesh Jevalikar, Jasjeet Singh Wasir and Beena Bansal. Their work appears in journals such as Diabetes & Metabolic Syndrome Clinical Research & Reviews, Archives of Osteoporosis, Diabetic Medicine, Advances in experimental medicine and biology and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.